CLINICAL_TRIALS
trial_result
· 2020-04-07
Clinical Trial Update: Study in Post-menopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer [Phase 3]
Summary
Phase 3 trial update for postmenopausal women with hormone receptor positive, HER2-negative advanced breast cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Post Menopausal Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2020-04-07